Related Experiment Video
Updated: Sep 10, 2025

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Recombinant Walnut-Derived Peptide Ameliorates d-Galactose-Induced Cognitive Deficits
Caiyun Li1,2, Dingwei Zheng1,2, Tianle Zhang1,2
1National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang A&F University, Hangzhou 311300, China.
Recombinant walnut-derived peptide (rWDP) improved cognitive function in aging mice by modulating gut microbiota and reducing neuroinflammation. This peptide shows promise for treating age-related cognitive decline via the gut-brain axis.
Area of Science:
- Neuroscience
- Microbiology
- Immunology
Background:
- Aging and neuroinflammation are linked to gut dysbiosis and systemic inflammation via the gut-brain axis.
- Bioactive peptides, like walnut-derived peptide EV-10, show therapeutic potential for neurodegenerative disorders.
- The therapeutic efficacy of recombinant walnut-derived peptide (rWDP) requires further characterization.
Purpose of the Study:
- To investigate the therapeutic potential of rWDP in a mouse model of aging.
- To elucidate the mechanisms underlying rWDP's effects on cognitive function, gut microbiota, and neuroinflammation.
Main Methods:
- Behavioral assessment using the Morris water maze in d-galactose-induced aging mice.
- Analysis of gut microbiota composition and colon mucosal integrity.
- Measurement of systemic inflammatory markers (IFN-γ, VCAM-1, G-CSF, CXCL1).
- Assessment of microglial activation and neuronal architecture in brain tissue.
- In vitro studies using BV2 microglial cells stimulated with LPS.
- Metabolomic analysis of brain tissue.
Main Results:
- rWDP significantly improved spatial learning and memory in aging mice.
- rWDP treatment altered gut microbiota, increasing Akkermansia muciniphila and improving colon mucosal integrity.
- Systemic inflammation was attenuated, with reduced IFN-γ and VCAM-1, and normalized G-CSF and CXCL1.
- rWDP reduced microglial activation and preserved hippocampal neuronal architecture, with decreased p21 expression in the brain.
- In vitro, rWDP suppressed LPS-induced nitric oxide production and pro-inflammatory gene expression in microglial cells.
- Metabolomic analysis indicated restoration of neurotransmitter homeostasis.
Conclusions:
- rWDP alleviates cognitive deficits in aging mice, potentially through the gut-brain axis and immune modulation.
- rWDP's effects involve beneficial alterations in gut microbiota and reduced neuroinflammation.
- Further research is warranted to fully elucidate the multifaceted mechanisms of rWDP action.
More Related Videos
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
Related Concept Videos
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists